235 related articles for article (PubMed ID: 20849603)
21. Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease.
Pesek M; Kopeckova M; Benesova L; Meszarosova A; Mukensnabl P; Bruha F; Minarik M
Anticancer Res; 2011 Dec; 31(12):4647-52. PubMed ID: 22199344
[TBL] [Abstract][Full Text] [Related]
22. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic inactivation of the RUNX3 gene in lung cancer.
Sato K; Tomizawa Y; Iijima H; Saito R; Ishizuka T; Nakajima T; Mori M
Oncol Rep; 2006 Jan; 15(1):129-35. PubMed ID: 16328045
[TBL] [Abstract][Full Text] [Related]
24. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas.
Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S
Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641
[TBL] [Abstract][Full Text] [Related]
25. Global methylation profiling of lung cancer identifies novel methylated genes.
Dai Z; Lakshmanan RR; Zhu WG; Smiraglia DJ; Rush LJ; Frühwald MC; Brena RM; Li B; Wright FA; Ross P; Otterson GA; Plass C
Neoplasia; 2001; 3(4):314-23. PubMed ID: 11571631
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
Nasif D; Campoy E; Laurito S; Branham R; Urrutia G; Roqué M; Branham MT
Clin Epigenetics; 2018 Aug; 10(1):111. PubMed ID: 30139383
[TBL] [Abstract][Full Text] [Related]
27. Methylation analysis for multiple gene promoters in non-small cell lung cancers in high indoor air pollution region in China.
Huang X; Wu C; Fu Y; Guo L; Kong X; Cai H
Bull Cancer; 2018 Sep; 105(9):746-754. PubMed ID: 30126609
[TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
[TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.
Verschuur-Maes AH; de Bruin PC; van Diest PJ
Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224
[TBL] [Abstract][Full Text] [Related]
31. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
[TBL] [Abstract][Full Text] [Related]
32. Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients.
Ponomaryova AA; Rykova EY; Cherdyntseva NV; Skvortsova TE; Dobrodeev AY; Zav'yalov AA; Bryzgalov LO; Tuzikov SA; Vlassov VV; Laktionov PP
Lung Cancer; 2013 Sep; 81(3):397-403. PubMed ID: 23806794
[TBL] [Abstract][Full Text] [Related]
33. Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.
Imoto I; Izumi H; Yokoi S; Hosoda H; Shibata T; Hosoda F; Ohki M; Hirohashi S; Inazawa J
Cancer Res; 2006 May; 66(9):4617-26. PubMed ID: 16651412
[TBL] [Abstract][Full Text] [Related]
34. DNA hypermethylation of tumors from non-small cell lung cancer (NSCLC) patients is associated with gender and histologic type.
Hawes SE; Stern JE; Feng Q; Wiens LW; Rasey JS; Lu H; Kiviat NB; Vesselle H
Lung Cancer; 2010 Aug; 69(2):172-9. PubMed ID: 19945765
[TBL] [Abstract][Full Text] [Related]
35. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y
Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787
[TBL] [Abstract][Full Text] [Related]
36. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
[TBL] [Abstract][Full Text] [Related]
37. Methylation profiling of archived non-small cell lung cancer: a promising prognostic system.
Safar AM; Spencer H; Su X; Coffey M; Cooney CA; Ratnasinghe LD; Hutchins LF; Fan CY
Clin Cancer Res; 2005 Jun; 11(12):4400-5. PubMed ID: 15958624
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
[TBL] [Abstract][Full Text] [Related]
39. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
40. Aberrant promoter methylation of cell adhesion-related genes associated with clinicopathologic features in non-small cell lung cancer in China.
Xu PW; Xu HY; Liu XN; Zhang CY; Tan C; Chen CM; Zhang H; Jin YT
Cancer Biomark; 2013; 13(2):115-22. PubMed ID: 23838140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]